All lobbying filings

CORNERSTONE GOVERNMENT AFFAIRS, INC.

CORNERSTONE GOVERNMENT AFFAIRS, INC. filed a Q4 report for THE UNITED STATES PHARMACOPEIAL CONVENTION on January 20, 2026, reporting $60,000 in lobbying income.

Lobbying for THE UNITED STATES PHARMACOPEIAL CONVENTION · Pharmaceuticals

All filings by CORNERSTONE GOVERNMENT AFFAIRS, INC. · Everything THE UNITED STATES PHARMACOPEIAL CONVENTION has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Lobbyists on this filing 1

ANDREW FLICK

Previously held: Spec Asst to the Pres & Sr Adv for Cong Affairs and Strategic Outreach, Office of the VP; Exec Dir, New Democrat Coalition; Chief of Staff (Trone); Dep Chief of Staff (Moulton); Leg Director (Costa); Leg Asst (Skelton)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Pharmacy

Issues related to strengthening the resiliency of the U.S. medical supply chain.

Medical/Disease Research/Clinical Labs

Issues related to strengthening the resiliency of the U.S. medical supply chain.

Trade (domestic/foreign)

Issues related to strengthening the resiliency of the U.S. medical supply chain.

Health Issues

Issues related to strengthening the resiliency of the U.S. medical supply chain.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.